AI assistant
Sending…
MASIMO CORP — Director's Dealing 2025
Jul 3, 2025
30755_dirs_2025-07-03_13624173-1b4c-44a2-9fc1-9bc172404c11.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Neuraxis, INC (NRXS)
CIK: 0001933567
Period of Report: 2025-07-01
Reporting Person: MASIMO CORP (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-01 | Common Stock | S | 531548 | $2.25 | Disposed | 0 | Direct |
| 2025-07-01 | Common Stock | C | 289779 | $0.0001 | Acquired | 289779 | Direct |
| 2025-07-01 | Common Stock | S | 289779 | $2.25 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-01 | Pre-Funded Warrant, Common Stock (Right to Buy) | $0.0005 | M | 289779 | Disposed | Common Stock (289779) | Direct |
Footnotes
F1: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.0005 per share of the Issuer's Common Stock.
More from MASIMO CORP
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 4
Annual Report
2026
May 1
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 26
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 17